These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23157040)

  • 1. Screening of cervical cancer: 27 years experience in six Republics of Panama.
    Garrido JL
    Clin Exp Obstet Gynecol; 2012; 39(3):343-5. PubMed ID: 23157040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial quickly changed management of cervical abnormalities.
    Zielinski SL
    J Natl Cancer Inst; 2005 Apr; 97(7):479-80. PubMed ID: 15812071
    [No Abstract]   [Full Text] [Related]  

  • 3. Twenty-five years of medical colposcopic rural tours in the Republic of Panama: commitment and integration in screening 1983-2008.
    Garrido JL
    Eur J Gynaecol Oncol; 2010; 31(4):434-6. PubMed ID: 20882888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 21-year-old woman with atypical squamous cells of undetermined significance.
    Sawaya GF
    JAMA; 2005 Nov; 294(17):2210-8. PubMed ID: 16264163
    [No Abstract]   [Full Text] [Related]  

  • 5. HPV testing in cervical cytology practice: it's all about choice.
    Stoler MH
    Acta Cytol; 2005; 49(2):117-9. PubMed ID: 15839612
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of human papillomavirus DNA in patients referred to a family practice colposcopy clinic.
    Holman JR
    J Am Board Fam Pract; 1996; 9(3):162-6. PubMed ID: 8743228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How technology and vaccination have changed the Pap test].
    Bondi A; Ghidoni D; Amadori A
    Pathologica; 1999 Feb; 91(1):36-41. PubMed ID: 10396949
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus testing for primary cervical cancer screening.
    Runowicz CD; Garozzo S
    Curr Oncol Rep; 2008 Nov; 10(6):533-7. PubMed ID: 18928670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cervical cancer screning: from cytology to HPV testing].
    Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing.
    Fokom Domgue J; Cunningham SA; Yu RK; Shete S
    Ann Epidemiol; 2019 Aug; 36():40-47. PubMed ID: 31320153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus and cervical disease in adolescents.
    Guido R
    Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
    JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ensuring quality in cervical screening programmes based on molecular human papillomavirus testing.
    Cuschieri K; Schuurman R; Coughlan S
    Cytopathology; 2019 May; 30(3):273-280. PubMed ID: 30657615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of HPV infection].
    Boulanger JC; Sevestre H; Bauville E; Ghighi C; Harlicot JP; Gondry J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):218-23. PubMed ID: 15123119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Summary of the practice guideline 'Prevention and early diagnosis of cervical cancer' of the Dutch College of General Practitioners].
    Janssen PG; Boomsma LJ; Buis PA; Collette C; Boukes FS; Goudswaard AN
    Ned Tijdschr Geneeskd; 2009; 153():A517. PubMed ID: 20051149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in cervical pathology: the perspective of the European colposcopists].
    Boulanger JC; Bergeron C
    Gynecol Obstet Fertil; 2005; 33(1-2):50-4. PubMed ID: 15752667
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncological risk, evaluation 1982-1989, Panama.
    Garrido JL
    Eur J Gynaecol Oncol; 1993; 14(1):68-70. PubMed ID: 8386084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.